Milnacipran for Chronic Pain in Knee Osteoarthritis
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The patients are asked to take part in this study because you have chronic pain as a result
of knee osteoarthritis. This study is done to investigate the pain relieving effects of the
study drug Savella (milnacipran HCl) for people who experience chronic osteoarthritis pain.
The purpose of this research is to look at how the study drug can be used to benefit people
who experience osteoarthritis knee pain. This is a phase IV study done to study the safety
and effectiveness of the drug. At this point the drug is already approved by the Food and
Drug Administration for people with fibromyalgia but it has not yet been approved for people
with knee osteoarthritis.